Vital Signs

Vital Signs

Home
Archive
About
Sword Health CEO Virgílio (“V”) Bento on Vital Signs
Sword's New AI Solution and Decisions That Shaped the Company
 • Jacob Effron, Nikhil Krishnan, and Eric Shan
Investing in Abridge
We’re thrilled to announce that Redpoint is co-leading Abridge’s $150M Series C.
 • Jacob Effron
Vital Signs Highlights
And a New Season Preview
 • Jacob Effron, Nikhil Krishnan, and Eric Shan
Mark Cuban on Disrupting PBMs, Staying Curious and Using AI to Avoid NBA Fines
On our latest Vital Signs episode, we talked about problems in pharmacy with Mark Cuban, founder of The Mark Cuban Cost Plus Drug Company.
 • Jacob Effron, Nikhil Krishnan, and Eric Shan
The Future of AI In Medical Diagnosis: In Conversation With PathAI CEO Dr. Andy Beck
For our second crossover episode between Vital Signs and Unsupervised Learning we explored the impact of AI on pathology with PathAI Co-Founder and CEO…
 • Jacob Effron
How Insitro Is Using AI to Create Better Medicines: In Conversation With Daphne Koller
On our first crossover episode between Unsupervised Learning and Vital Signs, we dove deep into the world of using AI in drug development with Insitro…
 • Jacob Effron
Optum's Evolution and Lessons from Obamacare and COVID: In Conversation with Andy Slavitt
On the latest Vital Signs, Nikhil and I chatted with Andy Slavitt, former Optum EVP, head of CMS, COVID advisor and healthcare.gov saver.
 • Jacob Effron
Vital Signs
Vital Signs
Health tech company, sub-sector and trend breakdowns
Recommendations
View all 6
Pear Healthcare Playbook
Pear Healthcare Playbook
VH12345
Health API Guy
Health API Guy
Brendan Keeler
Reprogramming Reality
Reprogramming Reality
Meera Clark
Two Docs and a Stack
Two Docs and a Stack
Arpan Parikh, MD MBA FAPA
Unsupervised Learning
Unsupervised Learning
Jacob Effron

Vital Signs

AboutArchiveRecommendationsSitemap
© 2026 Jacob Effron · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture